Concepedia

Author

Sylvia Adams

New York UniversityORCID

Also Known As

Adams S,, Adams, S, Corina Escamilla, Guntupalli, Kalpatha, Jessica Bon, Mohamed I. Abdalla, Roberto Salgado, S Adams, S. Adams, S. G. Adams

351

Publications

31K

Citations

72

H-Index

86

Concepts

All Affiliations

New York UniversityDana-Farber Cancer InstituteNYU Langone HealthPeter MacCallum Cancer CentreAichi Cancer Center
SA

About

Sylvia Adams is an author at New York University specializing in medicine, oncology, and breast cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

33

55

9K

2

Health Sciences

11

11

674

3

Allergy

3

3

397

4

Public Health

1

1

92

5

Biochemistry

1

1

120

Sylvia Adams

×

96

Publications

21.4K

Citations

52

H-Index

YearCitations

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

Peter Schmid, Sylvia Adams, Hope S. Rugo,

New England Journal of Medicine

2018

4.2K

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

Roberto Salgado, Carsten Denkert, Sandra Demaria,

Annals of Oncology

2014

3K

Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199

Sylvia Adams, Robert J. Gray, Sandra Demaria,

Journal of Clinical Oncology

2014

1.3K

Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial

Peter Schmid, Hope S. Rugo, Sylvia Adams,

The Lancet Oncology

2019

1.2K

Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

Sherene Loi, Damien Drubay, Sylvia Adams,

Journal of Clinical Oncology

2019

828

NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis

Samantha Alvarez, Vladislav O. Sviderskiy, Erdem M. Terzi,

Nature

2017

776

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study

Sylvia Adams, P. Schmid, H. S. Rugo,

Annals of Oncology

2018

756

Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial

Encouse B. Golden, Arpit M. Chhabra, Abraham Chachoua,

The Lancet Oncology

2015

637

Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study

Sylvia Adams, Sherene Loi, Deborah Toppmeyer,

Annals of Oncology

2018

608

First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis

Leisha A. Emens, Sylvia Adams, Carlos H. Barrios,

Annals of Oncology

2021

437

Page 1